PSYCHEDELIC-ASSISTED THERAPY GLOBAL SUMMIT
SCHEDULE
DAY 1
Indigenous, Eastern & Western Modes of Knowing: Mind, Consciousness, & Spirit
Stanislav Grof, PhD • Brigitte Grof, PhD • Deepak Chopra, MD • Cassandra Vieten, PhD • Anja Loizaga-Velder, PhD • Fleet Maull, PhD • Lewis Mehl-Madrona, MD
Explore Indigenous, Eastern, and Western Perspectives on mind, consciousness, and spirit on Day 1. Stanislav Grof, PhD and Brigitte Grof, PhD start the day exploring the parallels between psychedelics and holotropic breathwork in expanded states of consciousness, followed by Deepak Chopra, MD’s discussion on the secrets of quantum consciousness and healing through psychedelics. Cassandra Vieten, PhD. reveals what the research says about how psychedelics are useful in promoting spiritual and emotional well-being, while learning about sacred reciprocity in indigenous healing and how to give back to these traditions with Anja Loizaga-Velder. PhD. Fleet Maull, PhD, shares insights about the intersection in current developments of psychedelic medicines, and the day ends with Lewis Mehl-Madrona, MD, discussing the integration of Indigenous wisdom with contemporary healthcare.
DAY 2
Research, Rescheduling for Clinical Application & Decriminalization
Rick Doblin, PhD • Matthew Johnson, PhD • Paul Stamets • Rosalind Watts, PhD • Albert Garcia-Romeu, PhD • Christopher Timmermann, PhD • Patrick Fisher, PhD • A film screening of Way of the Psychonaut
The second day focuses on the clinical application, rescheduling, and decriminalization of psychedelics. Rick Doblin, PhD initiates our journey with a discussion on the changing cultural attitude towards psychedelics, followed by Matthew Johnson, PhD insights on psychedelics in addiction treatment, while Paul Stamets advocates for the future of psychedelics and planetary health. In addition, Rosalind Watts, PhD shares findings on psilocybin for depression and the importance of the therapeutic context, and Albert Garcia-Romeu, PhD examines the potential of psychedelics in addressing depression and anxiety, alongside Christopher Timmermann, PhD who delves into the intriguing world of 5-MeO-DMT and its unique cultural and psychological implications. Finally Patrick Fisher, PhD reveals the psychedelic neurobiological journey.
DAY 3
Therapeutic Applications for Specific MH Challenges & Healing Underlying Traumas
Bessel van der Kolk, MD • DaeEss 1Drea Pennington Wasio, MD • Brian Richards, PhD • Licia Sky • NiCole T. Buchanan, PhD • Peter Corbett, LICSW• Austin Perlmutter, MD • A film screening of DOSED
On Day Three, we examine therapeutic applications for specific mental health challenges. Bessel van der Kolk, MD provides strategies for exploring the depths of trauma and healing through psychedelic therapy, while DaeEss 1Drea Pennington Wasio discusses the role of self-love in healing trauma and fostering resilience, Brian Richards, PhD introduces how altered states of consciousness can help to reframe end of life anxiety, and Licia Sky bridges the somatic connection of art and music in psychedelics healing, alongside NiCole T. Buchanan, PhD who presents the concept of empowered consent as a critical aspect of therapy. Peter Corbett, LICSW shares the transformative power of ketamine-assisted therapy, and Austin Perlmutter MD ends the day with a discussion on epigenetics and how psychedelic experiences can induce lasting changes in DNA expression.
DAY 4
Practice: Therapeutic Approaches & Strategies, Dosing & Protocols for Safe Delivery
Andrew Weil, MD • Gita Vaid, MD • Michael Mithoefer, MD & Annie, BSN • Sunny Strasburg, LMFT • Ben Sessa, MD • Torsten Passie, MD • Ronald Siegel PsyD • A film screening of Psychedelia
Day Four delves into the nexus of emerging therapeutic strategies for dosing, and safe delivery. Andrew Weil, MD reveals the changing landscape of healthcare, where Integrative Medicine and complementary approaches tune into patient needs, followed by Gita Vaid’s, MD exploration of the parallels between ketamine experiences and meditation practices. Michael Mithoefer, MD & Annie, BSN examine the role of inner healing intelligence in psychedelic therapy, while Sunny Strasburg, LMFT connects the therapeutic experiences, with and without psychedelics. Ben Sessa, MD discusses emerging healthcare models, Torsten Passie, MD explores the therapeutic potentials of altered states and healing, and Ronald Siegel PsyD concludes the day with the power of Mindfulness and Compassion in psychedelic therapy.
DAY 5
Before and After Preparation & Integration for Optimal Treatment Effectiveness
Richard Schwartz, PhD • Steven C. Hayes, PhD • Clancy Cavnar, PsyD • Christopher Germer, PhD • Chen Lizra • Ryan Westrum • A film screening of DOSED: The Trip of a Lifetime & Participant Interview
Day Five explores the synergy of preparation and integration for treatment. Richard Schwartz, PhD elucidates how the Internal Family Systems model works with psychedelics to facilitate healing, followed by Steven C. Hayes, PhD insights into the foundations of Acceptance and Commitment Therapy. Clancy Cavnar, PsyD shares her method for empowering LGBTQ+ through psychedelic therapy, and Christopher Germer, PhD presents on self-compassion for creating a safe and transformative space, while Chen Lizra provides techniques on embodying compassion to unlocking somatic wisdom, and Ryan Westrum ends the day with methods for addressing client anxieties and uncertainties about psychedelic therapy.
DAY 6
Standards, Ethics, & Best Practices for Treatment & Training Therapists
Joseph McCowan, PsyD • Hannah McLane, MD • Michael Alpert, MD • Diana Quinn, ND • Ingmar Gorman, PhD • Kwasi Adusei, DNP, PMHNP • Erica Zelfand, ND
Day Six guides us towards ethics and best practices for treatment and training. Joseph McCowan, PsyD discusses the intricate connection between the therapist-patient relationship in psychedelic therapy. Hannah McLane, MD explores the similarities between psychoanalysis and psychedelic-assisted psychotherapy, followed by Michael Alpert’s, MD exploration of cost-effective psychedelic treatments. Diana Quinn, ND integrates expanded consciousness with the realities of systemic oppression, and Ingmar Gorman, PhD navigating the complexities of psychedelic-assisted training. Kwasi Adusei, DNP, PMHNP teaches on the critical role of community in ensuring safe and transformative psychedelic experiences, and the day concludes with Erica Zelfand’s, ND exploration of nature-honoring methodologies that seek to address root causes of health issues.
DAY 7
Delivery Infrastructure & Business Model - Diversity, Equity, Inclusion, & Accessibility
Monnica Williams, PhD • Victor Cabral, MSW, LSW • Deran Young, LCSW • Darron T. Smith, PhD • Charlotte James • Preeti Simran Sethi, MBA • Bia Labate, PhD • Hattie Wells • A film screening of We Are The Medicine & conversation with the filmmakers
Day 7 takes a deep dive into delivery infrastructure and DEIA. Monnica Williams, PhD explores psychedelics, race and cultural healing, followed by Victor Cabral, MSW, LSW who elucidates on psychedelic therapy's potential for supporting marginalized communities, and Deran Young, LCSW shares insights into profound psychological impacts of systemic oppression and how psychedelic can help heal. Darron T. Smith, PhD explores psychedelics' role in healing racial trauma, while Charlotte James shares her unique approach to building strong communities and fostering inclusivity, and Preeti Simran Sethi, MBA explores intergenerational healing. Bia Labate, PhD examines the power of psychedelics through the lens of cultural exploration, and the day ends with Hattie Wells’ investigation of ethics vs. profit in the integration of traditional ethno-botanicals into modern medicine.
